Aberrant expression of serum miRNAs in schizophrenia

Journal of Psychiatric Research

Volumn 46, Issue 2, 2012, Pages 198-204

  Shi, Wenting ^a   Du, Jinglun ^b   Qi, Yuhua ^c   Liang, Gaofeng ^a   Wang, Tianyu ^b   Li, Shuchun ^a   Xie, Shiping ^b   Zeshan, Basit ^a   Xiao, Zhongdang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

MicroRNA; Schizophrenia; Serum

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 1308; MICRORNA 17; MICRORNA 181B; MICRORNA 219 2 3P; MICRORNA 346; MICRORNA 92A; RISPERIDONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RISPERIDONE; ROC CURVE; SCHIZOPHRENIA; SERUM; YOUNG ADULT;

EID: 84855986592     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.09.010     Document Type: Article

References (32)

1. Ai J., Zhang R., Li Y., Pu J.L., Lu Y.J., Jiao J.D., et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications 2010, 391:73-77.
2. Arora A., McKay G.J., Simpson D.A.C. Prediction and verification of miRNA expression in human and rat retinas. Investigative Ophthalmology & Visual Science 2007, 48:3962-3967.
3. Ban T.A. Neuropsychopharmacology and the genetics of schizophrenia - a history of the diagnosis of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004, 28:753-762.
4. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA-a Publication of the RNA Society 2005, 11:241-247.
5. Beveridge N.J., Tooney P.A., Carroll A.P., Gardiner E., Bowden N., Scott R.J., et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Molecular Genetics 2008, 17:1156-1168.
6. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders - the Maudsley Twin psychosis series. Archives of General Psychiatry 1999, 56:162-168.
7. Chakravarti A., Little P. Nature, nurture and human disease. Nature 2003, 421:412-414.
8. Chang T.C., Mendell J.T. microRNAs in vertebrate physiology and human disease. Annual Review of Genomics and Human Genetics 2007, 8:215-239.
9. Chen C.F., Ridzon D.A., Broomer A.J., Zhou Z.H., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research 2005, 33.
10. Chen X., Ba Y., Ma L.J., Cai X., Yin Y., Wang K.H., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008, 18:997-1006.
11. Dinan T.G. MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. International Journal of Neuropsychopharmacology 2010, 13:395-404.
12. Ding X.C., Weiler J., Grosshans H. Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends in Biotechnology 2009, 27:27-36.
13. Faraone S.V., Brown C.H., Glatt S.J., Tsuang M.T. Preventing schizophrenia and psychotic behaviour: definitions and methodological issues. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie 2002, 47:527-537.
14. Faraone S.V., Tsuang M.T. Quantitative models of the genetic transmission of schizophrenia. Psychological Bulletin 1985, 98:41-66.
15. Farmer A.E., McGuffin P., Gottesman Twin concordance for dsm-iii schizophrenia - scrutinizing the validity of the definition. Archives of General Psychiatry 1987, 44:634-641.
16. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nature Reviews Genetics 2008, 9:102-114.
17. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., et al. Serum MicroRNAs are promising novel biomarkers. Plos One 2008, 3.
18. Huang Z.H., Huang D., Ni S.J.A., Peng Z.L., Sheng W.Q., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International Journal of Cancer 2010, 127:118-126.
19. Hunsberger J.G., Austin D.R., Chen G., Manji H.K. MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Medicine 2009, 11:173-182.
20. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., Huang J., Ramsey A.J., Caron M.G., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3507-3512.
21. Lang U.E., Puls I., Muller D.J., Strutz-Seebohm N., Gallinat J. Molecular mechanisms of schizophrenia. Cellular Physiology and Biochemistry 2007, 20:687-702.
22. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
23. Mellios N., Huang H.S., Baker S.P., Gaidzicka M., Ginns E., Akbarian S. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 2009, 65:1006-1014.
24. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10513-10518.
25. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der Putten H., Flor P.J., et al. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 2006, 31:1112-1122.
26. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology 2009, 112:55-59.
27. Rong H., Liu T.B., Yang K.J., Yang H.C., Wu D.H., Liao C.P., et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. Journal of Psychiatric Research 2011, 45:92-95.
28. Santosh P.S., Arora N., Sarma P., Pal-Bhadra M., Bhadra U. Interaction map and selection of microRNA targets in Parkinson's disease-related genes. Journal of Biomedicine and Biotechnology 2009.
29. Schultz S.H., North S.W., Shields C.G. Schizophrenia: a review. American Family Physician 2007, 75:1821-1829.
30. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 2004, 5.
31. Wu J., Xie X.H. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biology 2006, 7.
32. Zhu Y.L., Kalbfleisch T., Brennan M.D., Li Y. AMicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophrenia Research 2009, 109:86-89.